Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials
Objective: To conduct a meta-analysis of randomized controlled trials (RCTs) on the effects of atropine eye drop in slowing myopia progression. Methods: A systematic search of relevant articles was done through a computerized search on PubMed, Medline, Cochrane Library, and Google Scholar on June 16...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=11;spage=6668;epage=6677;aulast=Kumari |
_version_ | 1797954876403089408 |
---|---|
author | Shalini Kumari Raj Anand Shashank Tripathi Rajesh C Mishra Simant Kumar Jha |
author_facet | Shalini Kumari Raj Anand Shashank Tripathi Rajesh C Mishra Simant Kumar Jha |
author_sort | Shalini Kumari |
collection | DOAJ |
description | Objective: To conduct a meta-analysis of randomized controlled trials (RCTs) on the effects of atropine eye drop in slowing myopia progression. Methods: A systematic search of relevant articles was done through a computerized search on PubMed, Medline, Cochrane Library, and Google Scholar on June 16, 2022. A supplementary search was done on ClinicalTrials.gov on the same date. After thorough search and analysis, seven relevant RCTs, double-masked with atropine eye drop as intervention arm and placebo as control arm, were selected for meta-analysis. Jadad scoring was used to evaluate the quality of RCTs. The outcome measurements included in the present meta-analysis are mean changes in the spherical equivalent (SE) of myopic error, and mean changes in axial length (AL) during the study period. Result: Pooled summary effect size, calculated by random effect model, for SE of myopia progression was 1.08 with 95% confidence interval (CI) (0.31–1.86) which was statistically significant (P-value = 0.006). Pooled summary effect size, calculated by random effect model, for axial length was − 0.89 with 95% CI (−1.48 to − 0.30) which was statistically significant (P-value = 0.003). Conclusion: In summary, atropine was demonstrated to be effective in controlling myopia progression in children. Both outcome measures, mean SE changes and mean AL elongation responded to atropine intervention compared to placebo. |
first_indexed | 2024-04-10T23:25:28Z |
format | Article |
id | doaj.art-9a93faa052064824aedadf903e4e56c1 |
institution | Directory Open Access Journal |
issn | 2249-4863 |
language | English |
last_indexed | 2024-04-10T23:25:28Z |
publishDate | 2022-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Journal of Family Medicine and Primary Care |
spelling | doaj.art-9a93faa052064824aedadf903e4e56c12023-01-12T12:42:32ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632022-01-0111116668667710.4103/jfmpc.jfmpc_1339_22Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trialsShalini KumariRaj AnandShashank TripathiRajesh C MishraSimant Kumar JhaObjective: To conduct a meta-analysis of randomized controlled trials (RCTs) on the effects of atropine eye drop in slowing myopia progression. Methods: A systematic search of relevant articles was done through a computerized search on PubMed, Medline, Cochrane Library, and Google Scholar on June 16, 2022. A supplementary search was done on ClinicalTrials.gov on the same date. After thorough search and analysis, seven relevant RCTs, double-masked with atropine eye drop as intervention arm and placebo as control arm, were selected for meta-analysis. Jadad scoring was used to evaluate the quality of RCTs. The outcome measurements included in the present meta-analysis are mean changes in the spherical equivalent (SE) of myopic error, and mean changes in axial length (AL) during the study period. Result: Pooled summary effect size, calculated by random effect model, for SE of myopia progression was 1.08 with 95% confidence interval (CI) (0.31–1.86) which was statistically significant (P-value = 0.006). Pooled summary effect size, calculated by random effect model, for axial length was − 0.89 with 95% CI (−1.48 to − 0.30) which was statistically significant (P-value = 0.003). Conclusion: In summary, atropine was demonstrated to be effective in controlling myopia progression in children. Both outcome measures, mean SE changes and mean AL elongation responded to atropine intervention compared to placebo.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=11;spage=6668;epage=6677;aulast=Kumariatropinechildrenmyopiaprogressionrefractive errorvision |
spellingShingle | Shalini Kumari Raj Anand Shashank Tripathi Rajesh C Mishra Simant Kumar Jha Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials Journal of Family Medicine and Primary Care atropine children myopia progression refractive error vision |
title | Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials |
title_full | Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials |
title_fullStr | Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials |
title_full_unstemmed | Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials |
title_short | Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials |
title_sort | efficacy of atropine for myopia control in children a meta analysis of randomized controlled trials |
topic | atropine children myopia progression refractive error vision |
url | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=11;spage=6668;epage=6677;aulast=Kumari |
work_keys_str_mv | AT shalinikumari efficacyofatropineformyopiacontrolinchildrenametaanalysisofrandomizedcontrolledtrials AT rajanand efficacyofatropineformyopiacontrolinchildrenametaanalysisofrandomizedcontrolledtrials AT shashanktripathi efficacyofatropineformyopiacontrolinchildrenametaanalysisofrandomizedcontrolledtrials AT rajeshcmishra efficacyofatropineformyopiacontrolinchildrenametaanalysisofrandomizedcontrolledtrials AT simantkumarjha efficacyofatropineformyopiacontrolinchildrenametaanalysisofrandomizedcontrolledtrials |